Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-22 09:06 am Sale | 13G | CERO THERAPEUTICS HLDGS INC CERO | Shaolin Capital Management LLC | 0 0% | -748,264 (Position Closed) | View |
| 2024-02-20 5:18 pm Sale | 13D | CERO THERAPEUTICS HLDGS INC CERO | PHOENIX BIOTECH SPONSOR LLC | 1,015,000 6.8% | -4,281,246 (-80.84%) | View |
| 2024-02-08 12:31 pm Sale | 13G | CERO THERAPEUTICS HLDGS INC CERO | Saba Capital Management L.P. | 0 0% | -1,212,426 (Position Closed) | View |
| 2023-02-14 3:45 pm Unchanged | 13G | CERO THERAPEUTICS HLDGS INC CERO | GOLDMAN SACHS GROUP INC GS | 0 0% | 0 (Unchanged) | View |
| 2023-02-14 1:51 pm Sale | 13G | CERO THERAPEUTICS HLDGS INC CERO | Beryl Capital Management LLC | 0 0% | -1,230,264 (Position Closed) | View |
| 2023-02-14 06:39 am Purchase | 13G | CERO THERAPEUTICS HLDGS INC CERO | Saba Capital Management L.P. | 1,212,426 6.6% | 255,000 (+26.63%) | View |
| 2023-02-13 8:05 pm Purchase | 13G | CERO THERAPEUTICS HLDGS INC CERO | Shaolin Capital Management LLC | 748,264 6.58% | 748,264 (New Position) | View |
| 2023-02-13 5:21 pm Sale | 13G | BIOTECH ACQUISITION CO USD CL BIOT | GOLDMAN SACHS GROUP INC GS | 250,525 1.1% | -944,153 (-79.03%) | View |
| 2023-01-31 6:40 pm Unchanged | 13D | CERO THERAPEUTICS HLDGS INC CERO | PHOENIX BIOTECH SPONSOR LLC | 5,296,246 78.2% | 0 (Unchanged) | View |
| 2023-01-25 07:24 am Sale | 13G | CERO THERAPEUTICS HLDGS INC CERO | HIGHBRIDGE CAPITAL MANAGEMENT LLC | 0 0% | -1,037,794 (Position Closed) | View |
| 2022-05-06 4:53 pm Purchase | 13G | CERO THERAPEUTICS HLDGS INC CERO | Saba Capital Management L.P. | 957,426 5.2% | 957,426 (New Position) | View |
| 2022-02-14 4:47 pm Unchanged | 13G | PHOENIX BIOTECH ACQ CORP UNIT PBAXU | CANTOR FITZGERALD SECURITIES | 905,000 4.9% | 0 (Unchanged) | View |
| 2022-02-11 4:41 pm Purchase | 13G | CERO THERAPEUTICS HLDGS INC CERO | Beryl Capital Management LLC | 1,230,264 6.7% | 1,230,264 (New Position) | View |
| 2022-02-08 4:00 pm Purchase | 13G | CERO THERAPEUTICS HLDGS INC CERO | PHOENIX BIOTECH SPONSOR LLC | 5,296,246 23% | 5,296,246 (New Position) | View |
| 2022-02-03 08:21 am Purchase | 13G | CERO THERAPEUTICS HLDGS INC CERO | HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,037,794 5.64% | 1,037,794 (New Position) | View |
| 2021-10-22 08:30 am Purchase | 13G | PHOENIX BIOTECH ACQ CORP UNIT PBAXU | HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,037,142 5.64% | 1,037,142 (New Position) | View |
| 2021-10-18 5:02 pm Purchase | 13G | PHOENIX BIOTECH ACQ CORP UNIT PBAXU | Beryl Capital Management LLC | 1,230,266 6.7% | 1,230,266 (New Position) | View |
| 2021-10-18 11:54 am Purchase | 13G | PHOENIX BIOTECH ACQ CORP UNIT PBAXU | CANTOR FITZGERALD SECURITIES | 905,000 5.5% | 905,000 (New Position) | View |